Lanosterol Explained

Lanosterol is a tetracyclic triterpenoid and is the compound from which all animal and fungal steroids are derived. By contrast, plant steroids are produced via cycloartenol.[1] In the eyes of vertebrates, lanosterol is a natural constituent, having a role in maintaining health of the lens. Lanosterol is the precursor to cholesterol.

Biosynthesis

The biosynthesis of lanosterol has been intensively investigated.[2]

Description Illustration Enzyme --Squalene is oxidized to 2,3-oxidosqualene (squalene epoxide) -2,3-Oxidosqualene is converted to a protosterol cation and finally to lanosterol - (step 2) (step 2)

Elaboration of lanosterol under enzyme catalysis leads to other steroids. 14-Demethylation of lanosterol by CYP51 eventually yields cholesterol.

Research as an eye drop supplement

As a molecule naturally enriched in the eye lens, lanosterol is a component involved in maintenance of lens clarity.[3] [4] Its proposed mechanism of action is to inhibit the aggregation of crystallin proteins, which contribute to the clouding of vision by forming cataracts.[3] [4]

Lanosterol is under research for its potential as a therapeutic additive in eye drops to inhibit the aggregation of crystallin proteins and dissolve cataracts.[3] [4] However, supplemental lanosterol in eye drops appears to have limited solubility and poor bioavailability in the eye, and has not proved effective for inhibiting cataracts, as of 2020.[3] [4]

See also

Notes and References

  1. Schaller. Hubert. The role of sterols in plant growth and development. Progress in Lipid Research. May 2003. 42. 3. 163–175. 10.1016/S0163-7827(02)00047-4. 12689617.
  2. 10.1021/cr200021m . Biosynthesis of cholesterol and other sterols . 2011 . Nes . W. David . Chemical Reviews . 111 . 10 . 6423–6451 . 3191736 .
  3. Daszynski DM, Santhoshkumar P, Phadte AS, Sharma KK, Zhong HA, Lou MF, Kador PF. 3 . Failure of oxysterols such as lanosterol to restore lens clarity from cataracts . Scientific Reports . 9 . 1 . 8459 . June 2019 . 31186457 . 6560215 . 10.1038/s41598-019-44676-4.
  4. Xu J, Fu Q, Chen X, Yao K . Advances in pharmacotherapy of cataracts . Annals of Translational Medicine . 8 . 22 . 1552 . November 2020 . 33313297 . 7729355 . 10.21037/atm-20-1960. free.